Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
- 31 December 2010
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Vol. 1806 (2), 258-267
- https://doi.org/10.1016/j.bbcan.2010.06.001
Abstract
No abstract availableKeywords
This publication has 117 references indexed in Scilit:
- Cross-talk between miRNA and Notch signaling pathways in tumor development and progressionCancer Letters, 2010
- Implication of microRNAs in drug resistance for designing novel cancer therapyDrug Resistance Updates, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Epidermal Notch1 Loss Promotes Skin Tumorigenesis by Impacting the Stromal MicroenvironmentCancer Cell, 2009
- The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancerDrug Resistance Updates, 2009
- The Canonical Notch Signaling Pathway: Unfolding the Activation MechanismCell, 2009
- Emerging role of Notch in stem cells and cancerCancer Letters, 2008
- Synergistic effects of multiple natural products in pancreatic cancer cellsLife Sciences, 2008
- Role of mTOR in anticancer drug resistance: Perspectives for improved drug treatmentDrug Resistance Updates, 2008
- Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerationsDrug Resistance Updates, 2007